UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension

Clinical pharmacology and therapeutics, 1992-09, Vol.52 (3), p.314-323

1992

Volltextzugriff (PDF)

Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans

Clinical pharmacology and therapeutics, 1987-01, Vol.41 (1), p.26-30

1987

Volltextzugriff (PDF)

Automated heparin-delivery system to control activated partial thromboplastin time. Evaluation in normal volunteers

Circulation (New York, N.Y.), 1999-02, Vol.99 (6), p.751-756

1999

Volltextzugriff (PDF)

Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation

Therapeutic drug monitoring, 1985-01, Vol.7 (4), p.372-376

1985

Volltextzugriff (PDF)

Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function

European journal of clinical pharmacology, 1998-06, Vol.54 (4), p.341-345

1998

Volltextzugriff (PDF)

Hemodynamics, biochemical effects, and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects

Clinical pharmacology and therapeutics, 1993-05, Vol.53 (5), p.585-592

1993

Volltextzugriff (PDF)

Nifedipine: Kinetics and dynamics in healthy subjects

Clinical pharmacology and therapeutics, 1984-06, Vol.35 (6), p.742-749

1984

Volltextzugriff (PDF)

Pharmacokinetic Studies with a Dual-Release Formulation of Levodopa, a Novel Principle in the Treatment of Parkinson’s Disease

European neurology, 1998-01, Vol.39 (2), p.119-124

1998

Volltextzugriff (PDF)

Renin Release Regulation During Acute Renin Inhibition in Normal Volunteers

Hypertension (Dallas, Tex. 1979), 1991-09, Vol.18 (3), p.257-265

1991

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment

Therapeutic drug monitoring, 1999-06, Vol.21 (3), p.310-316

1999

Volltextzugriff (PDF)

Lack of Negative Inotropic Effects of the New Calcium Antagonist Ro 40–5967 in Patients with Stable Angina Pectoris

Journal of cardiovascular pharmacology, 1991-11, Vol.18 (5), p.746-751

1991

Volltextzugriff (PDF)

Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure

European journal of clinical pharmacology, 1998-03, Vol.54 (1), p.59-61

1998

Volltextzugriff (PDF)

Nifedipine, relationship between pharmacokinetics and pharmacodynamics

Clinical pharmacokinetics, 1987, Vol.12 (1), p.12-29

1987

Volltextzugriff (PDF)

Effect of the Renin Response During Renin Inhibition: Oral Ro 42–5892 in Normal Humans

Journal of cardiovascular pharmacology, 1991-09, Vol.18 (3), p.299-307

1991

Volltextzugriff (PDF)

Liquid chromatographic determination of nifedipine in plasma and of its main metabolite in urine

Journal of chromatography, 1984-06, Vol.308, p.209-216

1984

Volltextzugriff (PDF)

Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels

Transfusion clinique et biologique (Paris), 1998-06, Vol.5 (3), p.180-188

1998

Volltextzugriff (PDF)

Hemolysis on Intravenous Administration of a New Calcium Antagonist

Journal of cardiovascular pharmacology, 1995-06, Vol.25 (6), p.855-858

1995

Volltextzugriff (PDF)

Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function

European journal of clinical pharmacology, 1997, Vol.51 (6), p.489-491

1997

Volltextzugriff (PDF)

The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers

Drugs (New York, N.Y.), 1995, Vol.49 Suppl 2 (Supplement 2), p.346-348

1995

Volltextzugriff (PDF)

Nifedipine: Kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration

Clinical pharmacology and therapeutics, 1986-07, Vol.40 (1), p.21-28

1986

Volltextzugriff (PDF)

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

Clinical pharmacokinetics, 1988-11, Vol.15 (5), p.295-318

1988

Volltextzugriff (PDF)

Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertension

Clinical pharmacology and therapeutics, 1993-11, Vol.54 (5), p.567-577

1993

Volltextzugriff (PDF)

Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men

Clinical pharmacology and therapeutics, 1996-06, Vol.59 (6), p.675-685

1996

Volltextzugriff (PDF)

Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42–5892) in hypertensive patients

British journal of clinical pharmacology, 1993-12, Vol.36 (6), p.547-554

1993

Volltextzugriff (PDF)

Drug interactions with calcium antagonists

Pharmacology & therapeutics (Oxford), 1990, Vol.45 (1), p.109-136

1990

Volltextzugriff (PDF)

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hemodynamic and humoral effects of the novel calcium antagonist Ro 40-5967 in patients with hypertension

Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans

Automated heparin-delivery system to control activated partial thromboplastin time. Evaluation in normal volunteers

Interaction between digoxin and nifedipine at steady state in patients with atrial fibrillation

Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function

Hemodynamics, biochemical effects, and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects

Nifedipine: Kinetics and dynamics in healthy subjects

Pharmacokinetic Studies with a Dual-Release Formulation of Levodopa, a Novel Principle in the Treatment of Parkinson’s Disease

Renin Release Regulation During Acute Renin Inhibition in Normal Volunteers

Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment

Lack of Negative Inotropic Effects of the New Calcium Antagonist Ro 40–5967 in Patients with Stable Angina Pectoris

Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with chronic renal failure

Nifedipine, relationship between pharmacokinetics and pharmacodynamics

Effect of the Renin Response During Renin Inhibition: Oral Ro 42–5892 in Normal Humans

Liquid chromatographic determination of nifedipine in plasma and of its main metabolite in urine

Anti-D immunoglobulin in Rh(D) negative volunteers: clearance of Rh(D) positive red cells and kinetics of serum anti-D levels

Hemolysis on Intravenous Administration of a New Calcium Antagonist

Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function

The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers

Nifedipine: Kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration

Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics

Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertension

Incremental dosage of the new antipsychotic mazapertine induces tolerance to cardiovascular and cognitive effects in healthy men

Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42–5892) in hypertensive patients

Drug interactions with calcium antagonists

Suchergebnisse filtern